CLINICAL RESEARCH: HEART RHYTHM DISORDERS
Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
Ilan Goldenberg, MD*,*,
Arthur J. Moss, MD*,
Scott McNitt, MS*,
Wojciech Zareba, MD, PhD*,
W. Jackson Hall, PhD ,
Mark L. Andrews, BBS*,
David J. Wilber, MD ,
Helmut U. Klein, MD for the MADIT-II Investigators
* Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York
Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York
Cardiovascular Institute, Loyola University Medical Center, Maywood, Illinois
Division of Cardiology, University Hospital, Magdeburg, Germany
Manuscript received September 6, 2005;
revised manuscript received December 5, 2005,
accepted December 13, 2005.
* Reprint requests and correspondence: Dr. Ilan Goldenberg, Heart Research Follow-Up Program, Box 653, University of Rochester Medical Center, Rochester, New York 14642 (Email: ilan.goldenberg{at}heart.rochester.edu).
OBJECTIVES: The study was designed to assess the effect of elapsed time from coronary revascularization (CR) on the benefit of the implantable cardioverter-defibrillator (ICD) and the risk of sudden cardiac death (SCD) in patients with ischemic left ventricular dysfunction.
BACKGROUND: The ICD improves survival in appropriately selected high-risk cardiac patients by 30% to 54%. However, in the Coronary Artery Bypass Graft (CABG)-Patch trial no evidence of improved survival was shown among a similar population of patients in whom an ICD was implanted prophylactically at the time of elective CABG.
METHODS: The outcome by time from CR was analyzed in 951 patients in whom a revascularization procedure was performed before enrollment in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
RESULTS: The adjusted hazard ratio (HR) of ICD versus conventional therapy was 0.64 (p = 0.01) among patients enrolled more than six months after CR, whereas no survival benefit with ICD therapy was shown among patients enrolled six months or earlier after CR (HR = 1.19; p = 0.76). In the conventional therapy group, the risk of cardiac death increased significantly with increasing time from CR (p for trend = 0.009), corresponding mainly to a six-fold increase in the risk of SCD among patients enrolled more than six months after CR.
CONCLUSIONS: In patients with ischemic left ventricular dysfunction, the efficacy of ICD therapy after CR is time dependent, with a significant life-saving benefit in patients receiving device implantation more than six months after CR. The lack of ICD benefit when implanted early after CR may be related to a relatively low risk of SCD during this time period.
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass graft | | CHD = coronary heart disease | | CR = coronary revascularization | | ICD = implantable cardioverter-defibrillator | | MADIT = Multicenter Automatic Defibrillator Implantation Trial | | PCI = percutaneous coronary intervention | | SCD = sudden cardiac death |
|
Related Article
-
Tincture of Time: When to Implant a Prophylactic Cardioverter-Defibrillator Following Coronary Revascularization?
- Anne M. Gillis
J. Am. Coll. Cardiol. 2006 47: 1818-1819.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
J. Sjoblom, L. Ljung, M. Frick, M. Rosenqvist, and V. Frykman
Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines
Europace,
November 23, 2011;
(2011)
eur354v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. A. Fazal, M. G. D. Bates, I. G. Matthews, and A. J. Turley
Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
Interact CardioVasc Thorac Surg,
June 1, 2011;
12(6):
1010 - 1016.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Nageh, J. J. Kim, J. Chung, and J. F. Yao
The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery
Europace,
January 1, 2011;
13(1):
70 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. O. Sweeney
The Contradiction of Appropriate Shocks in Primary Prevention ICDs: Increasing and Decreasing the Risk of Death
Circulation,
December 21, 2010;
122(25):
2638 - 2641.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Pokushalov, A. Romanov, D. Prohorova, A. Cherniavsky, K. Goscinska-Bis, J. Bis, A. Bochenek, and A. Karaskov
Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony
Eur J Cardiothorac Surg,
December 1, 2010;
38(6):
773 - 780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kreuz, O. Balta, M. Linhart, R. Fimmers, L. Lickfett, F. Mellert, G. Nickenig, and J. O. Schwab
An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter/defibrillator for primary prevention
Europace,
October 1, 2010;
12(10):
1439 - 1445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. McComb
Primary prevention of sudden cardiac death after acute myocardial infarction: lessons from Leiden
Europace,
March 1, 2010;
12(3):
307 - 308.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, A. Yassin, L. Buga, A. Torabi, and A. L. Clark
Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT
Eur J Heart Fail,
December 1, 2009;
11(12):
1214 - 1219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G.F. Cleland, A. P. Coletta, A. L. Clark, and D. Cullington
Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA
Eur J Heart Fail,
June 1, 2009;
11(6):
622 - 630.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. H.L. Tang and S. Fremes
Invited Commentary
Ann. Thorac. Surg.,
May 1, 2009;
87(5):
1407 - 1408.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Shiga, N Hagiwara, H Ogawa, A Takagi, M Nagashima, T Yamauchi, Y Tsurumi, R Koyanagi, H Kasanuki, and for the Heart Institute of Japan Acute Myocardial
Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry
Heart,
February 1, 2009;
95(3):
216 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Piccini, J. R. Horton, L. K. Shaw, S. M. Al-Khatib, K. L. Lee, A. E. Iskandrian, and S. Borges-Neto
Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death
Circ Cardiovasc Imaging,
November 1, 2008;
1(3):
180 - 188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Herzog, J. W. Strief, A. J. Collins, and D. T. Gilbertson
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
Nephrol. Dial. Transplant.,
August 1, 2008;
23(8):
2629 - 2633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and A. J. Moss
Long QT Syndrome
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2291 - 2300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Ann Intern Med,
August 21, 2007;
147(4):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators
Circulation,
May 8, 2007;
115(18):
2451 - 2457.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Goldenberg and A. J. Moss
Reply
J. Am. Coll. Cardiol.,
January 2, 2007;
49(1):
125 - 125.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pascale and M. Fromer
Time Dependence of Defibrillator Benefit Postcoronary Revascularization
J. Am. Coll. Cardiol.,
January 2, 2007;
49(1):
124 - 125.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Gillis
Tincture of Time: When to Implant a Prophylactic Cardioverter-Defibrillator Following Coronary Revascularization?
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1818 - 1819.
[Full Text]
[PDF]
|
|
|
|
